Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Eisai Co. Ltd.
ESALFCurrent price
39.81 USD
0 USD (0.00%)
Last closed
5 718 JPY
Company
www.eisai.co.jp
ISIN
JP3160400002
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
TSE
Capitalization
1 642 294 866 297 JPY
Yield for 12 month
-34.76 %
1Y
3Y
5Y
10Y
15Y
ESALF
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, for Alzheimer's disease/Dementia with Lewy bodies; and Chocola BB plus for the preparation vitamin B2. It has strategic collaboration with Bristol Myers Squibb for the co-development and co-commercialization of farletuzumab ecteribulin antibody drug conjugate. Eisai Co., Ltd. was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan. Address: 4-6-10, Koishikawa, Tokyo, Japan, 112-8088
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 112 226.58 JPYP/E ratio
50.7338Dividend Yield
2.8 %Current Year
+740 687 617 537 JPY
Last Year
+743 334 816 963 JPY
Current Quarter
+188 758 005 936 JPY
Last Quarter
+190 222 902 857 JPY
Current Year
+562 965 767 256 JPY
Last Year
+565 752 766 148 JPY
Current Quarter
+149 058 001 931 JPY
Last Quarter
+154 168 664 716 JPY
Key Figures ESALF
1 year
3 years
5 years
10 years
EBITDA
71 330 595 894 JPY
Operating Margin TTM
PE Ratio
50.7338
Return On Assets TTM
1.46 %
PEG Ratio
–
Return On Equity TTM
3.85 %
Wall Street Target Price
1 112 226.58 JPY
Revenue TTM
732 792 947 724 JPY
Book Value
3 132.79 JPY
Revenue Per Share TTM
Dividend Share
159.77 JPY
Quarterly Revenue Growth YOY
-4 %
Dividend Yield
2.8 %
Gross Profit TTM
565 752 766 097 JPY
Earnings per share
113.63 JPY
Diluted Eps TTM
113.63 JPY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-47.9 %
Profit Margin
4.45 %
Dividend Analytics ESALF
Dividend growth over 5 years
7 %Continuous growth
–Payout Ratio 5 years average
50 %Dividend History ESALF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
160
Ex Dividend Date
27.09.2024
Forward Annual Dividend Yield
2.8 %
Last Split Factor
–
Payout Ratio
2.08 %
Last Split Date
–
Dividend Date
–
Stock Valuation ESALF
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
50.7338
Forward PE
32.6797
Enterprise Value Revenue
2.0189
Price Sales TTM
2.2411
Enterprise Value EBITDA
16.1418
Price Book MRQ
1.8584
Financials ESALF
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ESALF
For 52 weeks
4 978.85 JPY
8 840.67 JPY
50 Day MA
6 112.16 JPY
Shares Short Prior Month
–
200 Day MA
6 536.45 JPY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart